Page last updated: 2024-08-17

colchicine and Insulin Resistance

colchicine has been researched along with Insulin Resistance in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	2 (50.00)	2.80

Authors

Authors	Studies
Babyak, A; Biancotto, A; Brady, SM; Chivukula, KK; Dagur, PK; Demidowich, AP; Fantoni, G; Han, JM; Levine, JA; Miller, E; Patel, TP; Periwal, V; Remaley, AT; Sarrafan-Chaharsoughi, Z; Wolska, A; Yanovski, JA	1
Buch, BT; Gudiksen, A; Halling, JF; Kjøbsted, R; Olsen, MA; Pilegaard, H; Ringholm, S; Wojtaszewski, JFP	1
Brady, SM; Broadney, MM; Chen, KY; Demidowich, AP; Khan, SM; Levine, JA; Onyekaba, GI; Yanovski, JA	1
Davis, AI; Dedhia, N; Demidowich, AP; Yanovski, JA	1

Trials

2 trial(s) available for colchicine and Insulin Resistance

Article	Year
Effects of colchicine on lipolysis and adipose tissue inflammation in adults with obesity and metabolic syndrome. Obesity (Silver Spring, Md.), 2022, Volume: 30, Issue:2 Topics: Adipose Tissue; Adult; Biomarkers; Colchicine; Humans; Inflammation; Insulin; Insulin Resistance; Lipolysis; Metabolic Syndrome; Obesity	2022
Effects of colchicine in adults with metabolic syndrome: A pilot randomized controlled trial. Diabetes, obesity & metabolism, 2019, Volume: 21, Issue:7 Topics: Adult; Anti-Inflammatory Agents; Blood Glucose; C-Reactive Protein; Colchicine; Female; Humans; Insulin; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Obesity; Pilot Projects	2019

Other Studies

2 other study(ies) available for colchicine and Insulin Resistance

Article	Year
Colchicine treatment impairs skeletal muscle mitochondrial function and insulin sensitivity in an age-specific manner. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2020, Volume: 34, Issue:6 Topics: Age Factors; Animals; Autophagy; Colchicine; Deoxyglucose; Energy Metabolism; Female; Glucose Tolerance Test; Insulin; Insulin Resistance; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria, Muscle; Muscle, Skeletal; Oxidation-Reduction; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Signal Transduction	2020
Colchicine to decrease NLRP3-activated inflammation and improve obesity-related metabolic dysregulation. Medical hypotheses, 2016, Volume: 92 Topics: Adipose Tissue; Animals; Colchicine; Diabetes Mellitus, Type 2; Gout Suppressants; Humans; Immunity, Innate; Inflammasomes; Inflammation; Insulin Resistance; Macrophages; Metabolic Diseases; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Obesity; Risk Factors	2016

Article

Year

Colchicine treatment impairs skeletal muscle mitochondrial function and insulin sensitivity in an age-specific manner.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2020, Volume: 34, Issue:6

Topics: Age Factors; Animals; Autophagy; Colchicine; Deoxyglucose; Energy Metabolism; Female; Glucose Tolerance Test; Insulin; Insulin Resistance; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria, Muscle; Muscle, Skeletal; Oxidation-Reduction; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Signal Transduction

2020

Colchicine to decrease NLRP3-activated inflammation and improve obesity-related metabolic dysregulation.

Medical hypotheses, 2016, Volume: 92

Topics: Adipose Tissue; Animals; Colchicine; Diabetes Mellitus, Type 2; Gout Suppressants; Humans; Immunity, Innate; Inflammasomes; Inflammation; Insulin Resistance; Macrophages; Metabolic Diseases; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Obesity; Risk Factors

2016